Structure of the human Parkin ligase domain in an autoinhibited state
暂无分享,去创建一个
[1] E. Hirsch,et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. , 2003, Human molecular genetics.
[2] K. Lim,et al. Relative Sensitivity of Parkin and Other Cysteine-containing Enzymes to Stress-induced Solubility Alterations* , 2007, Journal of Biological Chemistry.
[3] H. Walden,et al. Autoregulation of Parkin activity through its ubiquitin‐like domain , 2011, The EMBO journal.
[4] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[5] W. Chazin,et al. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. , 2012, Molecular cell.
[6] Nathaniel Echols,et al. The Phenix software for automated determination of macromolecular structures. , 2011, Methods.
[7] Francis Barany,et al. Fabrication of DNA microarrays onto polymer substrates using UV modification protocols with integration into microfluidic platforms for the sensing of low-abundant DNA point mutations. , 2005, Methods.
[8] K. Lim,et al. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. , 2005, Human molecular genetics.
[9] I. Marín. RBR Ubiquitin Ligases: Diversification and Streamlining in Animal Lineages , 2009, Journal of Molecular Evolution.
[10] A. Whitworth,et al. Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin , 2010, Proceedings of the National Academy of Sciences.
[11] R. Youle,et al. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.
[12] N. Hattori,et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria , 2012, Nature Communications.
[13] H. Ploegh,et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.
[14] R. Youle,et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin , 2010, The Journal of cell biology.
[15] R. Klevit,et al. Following Ariadne's thread: a new perspective on RBR ubiquitin ligases , 2012, BMC Biology.
[16] Wei Jiang,et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. , 2009, The Journal of clinical investigation.
[17] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[18] M. Rapé,et al. The Ubiquitin Code , 2012, Annual review of biochemistry.
[19] Miratul M. K. Muqit,et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.
[20] C. Culmsee,et al. Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling , 2007, The Journal of Neuroscience.
[21] Karen Marder,et al. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. , 2008, Archives of neurology.
[22] H. Braak,et al. 100 years of Lewy pathology , 2013, Nature Reviews Neurology.
[23] K. Winklhofer,et al. Aberrant Folding of Pathogenic Parkin Mutants , 2008, Journal of Biological Chemistry.
[24] A. Brice,et al. Parkin occurs in a stable, non-covalent, ∼110-kDa complex in brain , 2008, The European journal of neuroscience.
[25] K. Lim,et al. Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination , 2011, PloS one.
[26] T. Sixma,et al. The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension , 2012, The EMBO journal.
[27] N. Thakor,et al. Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function* , 2003, Journal of Biological Chemistry.
[28] J. Chin,et al. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains , 2011, Proceedings of the National Academy of Sciences.
[29] Jin Man Kim,et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Sheldrick,et al. Crystallographic ab initio protein structure solution below atomic resolution , 2009, Nature Methods.
[31] Angela C. Poole,et al. The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway , 2010, PloS one.
[32] David Alderton,et al. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications , 2007, Nucleic acids research.
[33] A. Brice,et al. Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. , 2009, Biochemical and biophysical research communications.
[34] W. Wurst,et al. The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. , 2013, Molecular cell.
[35] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[36] K. Rittinger,et al. LUBAC synthesizes linear ubiquitin chains via a thioester intermediate , 2012, EMBO reports.
[37] David Komander,et al. Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.
[38] D. Adams,et al. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice , 2010, Proceedings of the National Academy of Sciences.
[39] Michael Lazarou,et al. PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding , 2013, The Journal of cell biology.
[40] V. Hristova,et al. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.
[41] Kalle Gehring,et al. Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation , 2013, Science.
[42] Danny T. Huang,et al. BIRC7–E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer , 2012, Nature Structural &Molecular Biology.
[43] B. Dye,et al. Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. , 2007, Annual review of biophysics and biomolecular structure.
[44] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[45] A. Ferrús,et al. Ariadne-1: a vital Drosophila gene is required in development and defines a new conserved family of ring-finger proteins. , 2000, Genetics.
[46] Keiji Tanaka,et al. A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.
[47] H. Walden,et al. Regulation of Parkin E3 ubiquitin ligase activity , 2012, Cellular and Molecular Life Sciences.
[48] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[49] Ted M. Dawson,et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.
[50] G. Dorn,et al. PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.
[51] K. Lim,et al. Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease‐linked point mutations , 2005, Journal of neurochemistry.
[52] C. Sander,et al. Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies , 2010, Nature Genetics.
[53] F. Eisenhaber,et al. The ring between ring fingers (RBR) protein family , 2007, Genome Biology.
[54] N. Hattori,et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.
[55] M. Ruberg,et al. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates , 2003, Neurobiology of Disease.
[56] C. Lima,et al. Structural biology: A protein engagement RING , 2012, Nature.
[57] A. Brice,et al. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. , 2006, Human molecular genetics.
[58] V. Hristova,et al. Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin* , 2009, Journal of Biological Chemistry.
[59] Sebastian A. Wagner,et al. E3-independent monoubiquitination of ubiquitin-binding proteins. , 2007, Molecular cell.
[60] Ping Wang,et al. Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.
[61] Atsushi Tanaka,et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.
[62] R. Youle,et al. Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.
[63] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Gillis,et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.
[65] C. Culmsee,et al. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[66] M. Scheffner,et al. The Ubiquitin-conjugating Enzymes UbcH7 and UbcH8 Interact with RING Finger/IBR Motif-containing Domains of HHARI and H7-AP1* , 1999, The Journal of Biological Chemistry.
[67] Kenneth Wu,et al. Structure of the C-terminal RING finger from a RING-IBR-RING/TRIAD motif reveals a novel zinc-binding domain distinct from a RING. , 2004, Journal of molecular biology.
[68] Rachel E. Klevit,et al. UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids , 2011, Nature.
[69] N. Hattori,et al. Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro* , 2006, Journal of Biological Chemistry.
[70] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[71] Michael P Robertson,et al. The origins of the RNA world. , 2012, Cold Spring Harbor perspectives in biology.
[72] Serge X. Cohen,et al. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 , 2008, Nature Protocols.
[73] James H. Naismith,et al. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis , 2012, Nature.
[74] Xinnan Wang,et al. PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility , 2011, Cell.
[75] Steven P. Gygi,et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization , 2013, Nature.
[76] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[77] Yili Yang,et al. Expression and evaluation of RING finger proteins. , 2005, Methods in enzymology.
[78] David Komander,et al. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site , 2002, The EMBO journal.